Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Epilepsia|May 16, 2014
Towards the identification of a genetic basis for Landau-Kleffner syndromeJudith Conroy, Paul A McGettigan, Dara McCreary, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2006
Multireplicon genome architecture of Lactobacillus salivariusMarcus J Claesson, Yin Li, Sinead Leahy, et al.
Annals of Internal Medicine|April 3, 2023
Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort StudyKevin E Kip, Erin K McCreary, Kevin Collins, et al.
Open Forum Infectious Diseases|November 3, 2022
Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant EraErin K McCreary, Kevin E Kip, Kevin Collins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2018
Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 TrialSandro Virgilio Porceddu, Mathias Bressel, Michael Geoffrey Poulsen, et al.
Open Forum Infectious Diseases|July 12, 2021
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJ Ryan Bariola, Erin K McCreary, Richard J Wadas, et al.
Contemporary Clinical Trials|December 13, 2021
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 daysErin K McCreary, J Ryan Bariola, Tami Minnier, et al.
JAMA Network Open|April 12, 2022
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19Erin K McCreary, J Ryan Bariola, Richard J Wadas, et al.
The Journal of Infectious Diseases|November 16, 2023
Prospective Assessment of Humoral and Cellular Immune Responses to a Third COVID-19 mRNA Vaccine Dose Among Immunocompromised IndividualsGhady Haidar, Jacob C Hodges, Andrew Bilderback, et al.
Trials|May 26, 2021
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomizationDavid T Huang, Erin K McCreary, J Ryan Bariola, et al.
Pageof 5